Research shows weight loss surgery can help reduce the risk of severe liver problems for some patients with MASH.

Fatty liver disease occurs when more than 5-10% of the liver's weight is made up of fat. This can lead to inflammation in the ...

Fatty liver disease occurs when excess fat gets deposited in the liver due to reasons other than alcohol. (Image Credits: Pixabay) Fatty liver disease, medically known as hepatic steatosis, is ...

Fact checked by Nick Blackmer Fatty liver disease is often called a “silent epidemic” because it can progress for years ...

About 84 per cent IT employees in India have fatty liver disease while around 71 per cent are obese, says a study ...

A study found that if metabolic abnormal fatty liver disease persists, people have a 57% higher risk of cardiovascular ...

Resmetirom offers a targeted approach to metabolic dysfunction–associated steatohepatitis (MASH) for use alongside lifestyle ...

Weight loss is a key effect of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), but these drugs may also provide liver ...

Nonalcoholic fatty liver disease (NAFLD) and its progressive form, nonalcoholic steatohepatitis (NASH) are the most common causes of chronic liver disease in industrialized countries. NAFLD has ...

Nonalcoholic fatty liver disease (NAFLD ... hypertension and hyperlipidemia. Nonalcoholic steatohepatitis (NASH) is the progressive form of liver injury that carries a risk for progressive ...

One of these is non-alcoholic steatohepatitis, or NASH, the fatty liver disease that affects millions of people and which is poised to be one of pharma’s next big growth areas. Novartis ramped ...

MASH (formally known as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), respectively). These diseases are becoming increasingly common due to lifestyle changes ...